Suven Life Sciences Limited | SUVEN | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 92 | 208 | 136 | 151 | 466 |
Short-term investment |
| 3,009 | 2,787 | 2,300 | 0.49 | 0.86 |
Accounts receivables |
| 458 | 615 | 1,501 | 23 | 18 |
Inventories |
| 925 | 1,395 | 1,571 | 0 | 1 |
Deferred income taxes |
| 64 | 34 | 41 | 46 | 53 |
Other current assets |
| 369 | 583 | 683 | 440 | 487 |
Total current assets |
| 4,917 | 5,622 | 6,232 | 660 | 1,027 |
Gross property plant... |
| 3,045 | 3,049 | 2,906 | 206 | 177 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 3,045 | 3,049 | 2,906 | 206 | 177 |
Work in Progress |
| 97 | 247 | 1,111 | 0 | 48 |
Miscellaneous Investment |
| 1 | 62 | 45 | 913 | 0 |
Deferred income taxes |
| 19 | 0.2 | 0 | 0 | 0 |
Intangible assets |
| 12 | 28 | 27 | 2 | 1 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 66 | 126 | 68 | 39 | 31 |
Total non-current assets |
| 3,240 | 3,513 | 4,157 | 1,159 | 257 |
Total assets |
| 8,157 | 9,135 | 10,389 | 1,819 | 1,284 |
Short-term debt |
| 305 | 249 | 353 | 0 | 0 |
Accounts Payable... |
| 379 | 568 | 607 | 58 | 30 |
Provisions |
| 40 | 47 | 23 | 7 | 8 |
Taxes Payable |
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenues |
| 3 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 10 | 11 |
Other current liabilities |
| 459 | 303 | 508 | 189 | 110 |
Total current liabilities |
| 1,186 | 1,168 | 1,490 | 265 | 159 |
Long-term debt |
| 259 | 14 | 18 | 11 | 4 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 232 | 489 | 59 | 0 |
Provisions |
| 28 | 37 | 74 | 17 | 17 |
Capital Leases |
| 0 | 0 | 0 | 29 | 23 |
Other longterm liabilities |
| 13 | 10 | 8 | 5 | 0.56 |
Total non-current liabilities |
| 301 | 294 | 589 | 121 | 45 |
Total liabilities |
| 1,487 | 1,461 | 2,079 | 386 | 204 |
Share Capital |
| 127 | 127 | 127 | 127 | 127 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 6,543 | 7,547 | 8,183 | 1,306 | 584 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 369 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 6,670 | 7,674 | 8,310 | 1,433 | 1,080 |
Total Liabilities and Equity |
| 8,157 | 9,135 | 10,389 | 1,819 | 1,284 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |